L&G Pharma Breakthrough UCITS ETF (BIOT.L) — ETF Analysis on Winston
Key Facts
- Issuer: L&G
- Asset Class: Stock
- Price: $15.75
- Expense Ratio: 49.00%
- Assets Under Management: $21M
- Number of Holdings: 0
- Inception Date: 2018-01-23
- Currency: GBP
Winston Score
L&G Pharma Breakthrough UCITS ETF has a Winston Score of 50 out of 100.
Performance
- 1-Year Return: 32.36%
- 3-Year Return: 19.66%
- 5-Year Return: 7.56%
Top Holdings
TRAVERE THERAPEUTICS INC USD 0.0001 (N/A%), XENCOR INC USD 0.01 (N/A%), LIGAND PHARMACEUTICALS IN USD 0.001 (N/A%), JAZZ PHARMACEUTICALS PLC USD 0.0001 (N/A%), XERIS BIOPHARMA HLDGS IN USD 0.0001 (N/A%)
Sector Breakdown
Basic Materials (N/A%), Healthcare (N/A%)